• Target：
• GCDFP-15

• Gene Name：
• PIP GCDFP15 GPIP4

• Protein Name：
• BRST-2;BRST2;GCDFP-15;GCDGP15;gp17;GPIP4;Gross cystic disease fluid protein 15;PIP;PIP_HUMAN;Prolactin induced protein;Prolactin inducible protein precursor;Prolactin-induced protein;Prolactin-inducib

• Human Swiss Prot No：
• P12273

• Mouse Swiss Prot No：
• P02816

• Rat Swiss Prot No：
• O70417

• Immunogen：
• Synthesized peptide derived from human GCDFP-15 AA range: 50-146

• Specificity：
• The antibody can specifically recognize human GCDFP-15 protein.

• Formulation：
• The prediluted ready-to-use antibody is diluted in phosphate buffer saline containing stabilizing protein and 0.05% Proclin 300

• Source：
• Mouse, Monoclonal/IgG1, kappa

• Dilution：
• Ready to use for IHC

• Purification：
• The antibody was affinity-purified from ascites by affinity-chromatography using specific immunogen.

• Storage Stability：
• 2°C to 8°C/1 year

• Other Name：
• BRST-2;BRST2;GCDFP-15;GCDGP15;gp17;GPIP4;Gross cystic disease fluid protein 15;PIP;PIP_HUMAN;Prolactin induced protein;Prolactin inducible protein precursor;Prolactin-induced protein;Prolactin-inducible protein;SABP;Secretory actin binding protein;Secretory actin-binding protein

• Function：
• induction:By prolactin and androgen; inhibited by estrogen.,similarity:Belongs to the PIP family.,subunit:Monomer. Interacts with AZGP1.,tissue specificity:Expressed in pathological conditions of the mammary gland and in several exocrine tissues, such as the lacrimal, salivary, and sweat glands.,

• Subcellular Location：
• Cytoplasmic

• Expression：
• Breast

• June 19-2018
• WESTERN IMMUNOBLOTTING PROTOCOL

• June 19-2018
• IMMUNOHISTOCHEMISTRY-PARAFFIN PROTOCOL

• June 19-2018
• IMMUNOFLUORESCENCE PROTOCOL

• September 08-2020
• FLOW-CYTOMEYRT-PROTOCOL

• May 20-2022
• Cell-Based ELISA│解您多样本WB检测之困扰

• July 13-2018
• CELL-BASED-ELISA-PROTOCOL-FOR-ACETYL-PROTEIN

• July 13-2018
• CELL-BASED-ELISA-PROTOCOL-FOR-PHOSPHO-PROTEIN

• July 13-2018
• CELL-BASED-COLORIMETRIC-ELISA-PROTOCOL-FOR-TOTAL-PROTEIN

• July 13-2018
• Antibody-FAQs